Patent · US Expired

1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives

US7645760B2 · kind B2 · utility

2Cited by

2References

6Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Birgit Bollbuck · Munich, DE
Jorg Eder · Rheinfelden (Baden), DE
Richard Heng · Hégenheim, FR
Laszio Revesz · Therwil, CH
Achim Schlapbach · Bad Kötzting, DE
Rudolf Walchli · Basel, CH

Key dates

Filing date	Oct 24, 2003
Grant date	Jan 12, 2010
Priority date	—
Expiry date	Aug 2, 2025

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D233/74
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is implicated, e.g. inflammatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.